Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GERN
GERN logo

GERN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Geron Corp (GERN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.250
1 Day change
52 Week Range
2.010
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Geron Corp is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is weak technically, lacks recent news catalysts, and has no strong proprietary buy signal. While options sentiment is mildly bullish and hedge funds have been buying, the current setup does not offer a clear, high-confidence long-term entry at the moment. My direct view: hold off for now rather than buy immediately.

Technical Analysis

GERN is in a bearish short-term to medium-term trend. The MACD histogram is negative and still below zero, showing bearish momentum. The moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, which confirms the downtrend. RSI_6 at 28.494 is near oversold territory but not yet giving a strong reversal confirmation. Price is trading below the pivot at 1.299, with support at 1.213 and then 1.16, while resistance sits at 1.385 and 1.438. Pre-market price is 1.27, only slightly above the previous close area, so there is no clear breakout signal. The short-term pattern data suggests limited near-term upside, with a projected 40% chance of only modest gains over the next day and week.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish by positioning and trading flow. The put-call ratios are low, which typically signals more call activity than put activity. Call open interest is 37,363 versus put open interest of 15,606, and daily option volume is heavily call-skewed at 332 calls versus 14 puts. However, implied volatility is elevated at 59.17, and the IV percentile/rank are low-to-moderate, so the options market is active but not showing a clean long-term edge. Overall, options lean bullish, but not strongly enough to override the weak chart.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • ["Hedge funds are buying, with buying amount up 226.92% over the last quarter.", "Options sentiment is bullish, with low put-call ratios and much heavier call activity.", "Pre-market price is up 1.60%, suggesting some early demand."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh catalyst driving the stock.", "Technical trend is bearish: MACD below zero and bearish moving-average alignment.", "Price remains below key pivot resistance and has not confirmed a reversal.", "No significant insider buying; insiders are neutral over the last month.", "No recent congress trading data or influential figure activity to support sentiment."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial data returned an error. As a result, I cannot confirm revenue, earnings, or growth trends for the latest quarter season.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided. Therefore, I cannot report a recent analyst upgrade/downgrade trend or Wall Street consensus shift. Based on the data available, Wall Street pros appear mixed to cautious: hedge funds are accumulating, but the technical picture and lack of news do not support a strong bullish consensus.

Wall Street analysts forecast GERN stock price to rise
4 Analyst Rating
Wall Street analysts forecast GERN stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 1.250
sliders
Low
4
Averages
4
High
4
Current: 1.250
sliders
Low
4
Averages
4
High
4
TD Cowen
Tara Bancroft
Buy
downgrade
$4 -> $3
AI Analysis
2026-01-29
Reason
TD Cowen
Tara Bancroft
Price Target
$4 -> $3
AI Analysis
2026-01-29
downgrade
Buy
Reason
TD Cowen analyst Tara Bancroft lowered the firm's price target on Geron to $3 from $4 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Goldman Sachs
initiated
$1
2025-07-10
Reason
Goldman Sachs
Price Target
$1
2025-07-10
initiated
Reason
Goldman Sachs resumed coverage of Geron with a Sell rating and $1 price target, which suggests 31% downside. The initial launch of the company's lead product and first commercial drug, Rytelo, has disappointed, and the near-term trajectory for the launch will be modest, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GERN
Unlock Now

People Also Watch